MCMCB Pro
J1436

J1436Injection, etidronate disodium, per 300 mg

HCPCSActiveBETOS O1E

J1436 is a HCPCS Level II code for injection, etidronate disodium, per 300 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J1436 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Drug discontinued
outpatient
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Drug discontinued
DME supplier
0 — never payable
MAI 3 — Date of Service Edit: Clinical · Drug discontinued

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J1436

Long descriptor
Injection, etidronate disodium, per 300 mg

The official wording. This is what the code means.

Short descriptor
Etidronate disodium inj

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1990

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J1436

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1436 is not quite right, the correct code is very often within a few positions of it.

  • J1414Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
  • J1426Injection, casimersen, 10 mg
  • J1427Injection, viltolarsen, 10 mg
  • J1428Injection, eteplirsen, 10 mg
  • J1429Injection, golodirsen, 10 mg
  • J1430Injection, ethanolamine oleate, 100 mg
  • J1434Injection, fosaprepitant (focinvez), 1 mg
  • J1435Injection, estrone, per 1 mg
  • J1437Injection, ferric derisomaltose, 10 mg
  • J1438Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J1439Injection, ferric carboxymaltose, 1 mg
  • J1440Fecal microbiota, live - jslm, 1 ml
  • J1442Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
  • J1443Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of ironterminated
  • J1444Injection, ferric pyrophosphate citrate powder, 0.1 mg of ironterminated
  • J1445Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of ironterminated

Questions about J1436

What is HCPCS code J1436?

J1436 is a HCPCS Level II code for injection, etidronate disodium, per 300 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J1436?

The CMS HCPCS file marks J1436 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J1436 paid under the physician fee schedule?

J1436 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026